Photochemical decontamination of red blood cell concentrates with the silicon phthalocyanine PC 4 and red light
- PMID: 10794102
Photochemical decontamination of red blood cell concentrates with the silicon phthalocyanine PC 4 and red light
Abstract
Various approaches are being developed for virus inactivation of red blood cell concentrates (RBCC) in order to increase the safety of the blood supply. We have been studying the silicon phthalocyanine Pc 4 for this purpose, a photosensitizer activated with red light. Pc 4 targets the envelope of pathogenic viruses such as HIV. To protect RBC during the process two main approaches are used: (i) inclusion of quenchers of reactive oxygen species produced during the treatment. Tocopherol succinate was found to be most effective for this purpose; (ii) formulation of Pc 4, a lipophilic compound, in liposomes that reduce its binding to RBC but not to viruses. As a light source we used a light emitting diode array emitting at 670-680 nm. An efficient mixing device ensures homogenous light exposure during treatment of intact RBCC. Treatment of 50 ml RBCC with 5 microM Pc 4 and 18 J/cm(2) light results in the inactivation of > or = 5.5 log(10) HIV, > or = 6.3 log(10), VSV and > or = 5 log(10) of PRV and BVDV. The relative sensitivities of these viruses based on the slope of virus kill versus light dose are 1.0, 1.25, 1.5 and 1.9 for HIV, VSV, PRV and BVDV, respectively. To achieve the same level of virus inactivation in 350 ml RBCC, the light dose needed is 40 J/cm(2). HIV actively replicating in CEM cells is as sensitive as cell-free and HIV in latently infected cells is 3-4 times more sensitive. Parasites that can be transmitted by blood transfusion (P. falciparum and T. cruzi) are even more sensitive than viruses. Following treatment, RBCC can be stored for 28 days at 4 degrees C with haemolysis below 1%. Previous studies under less favourable conditions showed that baboon RBC circulated with an acceptable 24 hr recovery and half-life. Genetic toxicological studies of Pc 4 with or without light exposure (mutagenicity in bacteria, mammalian cells in vitro and clastogenicity in vivo) were negative. We conclude that a process using Pc 4 and red light can potentially reduce the risk of transmitting pathogens in RBCC.
Similar articles
-
Biodistribution and virus inactivation efficacy of a silicon phthalocyanine in red blood cell concentrates as a function of delivery vehicle.Photochem Photobiol. 1995 Sep;62(3):575-9. doi: 10.1111/j.1751-1097.1995.tb02387.x. Photochem Photobiol. 1995. PMID: 8570715
-
Inactivation of viruses in red cell and platelet concentrates with aluminum phthalocyanine (AIPc) sulfonates.Blood Cells. 1992;18(1):141-9; discussion 150. Blood Cells. 1992. PMID: 1617188
-
Differential sensitivities of pathogens in red cell concentrates to Tri-P(4)-photoinactivation.Vox Sang. 2006 Aug;91(2):111-8. doi: 10.1111/j.1423-0410.2006.00791.x. Vox Sang. 2006. PMID: 16907871
-
The use of dimethylmethylene blue for virus photoinactivation of red cell suspensions.Dev Biol (Basel). 2000;102:125-9. Dev Biol (Basel). 2000. PMID: 10794099 Review.
-
Viral safety of solvent-detergent treated blood products.Dev Biol Stand. 1993;81:147-61. Dev Biol Stand. 1993. PMID: 8174797 Review.
Cited by
-
Salivary human immunodeficiency virus (HIV)-1-specific immunoglobulin A in HIV-1-exposed infants in Kenya.Clin Exp Immunol. 2008 Jul;153(1):37-43. doi: 10.1111/j.1365-2249.2008.03664.x. Epub 2008 May 23. Clin Exp Immunol. 2008. PMID: 18505437 Free PMC article.
-
Photodynamic Therapy for Cancer: What's Past is Prologue.Photochem Photobiol. 2020 May;96(3):506-516. doi: 10.1111/php.13190. Epub 2020 Jan 7. Photochem Photobiol. 2020. PMID: 31820824 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials